These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 4929302)
1. [Malignant hypertension with special reference to the role of aldosterone]. Tanaka K; Kawasaki T; Omae T Nihon Rinsho; 1971 Mar; 29(3):918-21. PubMed ID: 4929302 [No Abstract] [Full Text] [Related]
2. The role of adrenal mineralocorticoids in hypertension. Tuck M Geriatrics; 1978 Jan; 33(1):77-83. PubMed ID: 620928 [No Abstract] [Full Text] [Related]
3. [A case of hyperaldosteronism in childhood]. Cserháti E; Körner A Orv Hetil; 1980 Jun; 121(24):1453-5. PubMed ID: 6108546 [No Abstract] [Full Text] [Related]
4. [Primary and secondary aldosteronism in hypertension]. Mertz DP Z Allgemeinmed; 1974 Apr; 50(12):566-71. PubMed ID: 4365194 [No Abstract] [Full Text] [Related]
5. [Effect of hypotensive drug therapy on hyperaldosteronism associated with malignant hypertension]. Januszewicz W; Johannsen Z; Wocial B Pol Arch Med Wewn; 1965; 35(11):1649-52. PubMed ID: 5862925 [No Abstract] [Full Text] [Related]
6. Etiology and management of malignant hypertension. Sesoko S; Ishikawa Y; Ishii M Compr Ther; 1988 Aug; 14(8):19-24. PubMed ID: 3168428 [No Abstract] [Full Text] [Related]
7. [Diagnosis and therapy of arterial hypertension. Significance of the renin-angiotensin-aldosterone system in differential diagnosis and therapy]. Nast HP; Philipp T Fortschr Med; 1974 Apr; 92(11):447-51. PubMed ID: 4362672 [No Abstract] [Full Text] [Related]
8. [Malignant hypertension]. Arita M; Nishio I Ryoikibetsu Shokogun Shirizu; 1996; (12):17-21. PubMed ID: 9047399 [No Abstract] [Full Text] [Related]
9. Correlation of plasma renin activity and aldosterone secretion rate in hypertensive patients. Schönbeck M; Siegenthaler W; Weidmann P; Endres P; Baumann K; Gysling E; Werning C Helv Med Acta; 1969 Jan; 34(5):386-400. PubMed ID: 5766169 [No Abstract] [Full Text] [Related]
10. [Malignant hypertension]. van Ypersele de Strihou C; Loute G Rev Med Suisse Romande; 1974 Nov; 94(11):903-7. PubMed ID: 4155113 [No Abstract] [Full Text] [Related]
11. Malignant hypertension in a patient with Conn's syndrome. Baxter RH; Wang I Scott Med J; 1974 Jul; 19(4):161-3. PubMed ID: 4837570 [No Abstract] [Full Text] [Related]
12. Malignant hypertension secondary to cortisol-secreting adrenal tumour. Weng SW; Yang CH; Huang WT; Chen MC; Wang PW N Z Med J; 2005 Jun; 118(1216):U1498. PubMed ID: 15937532 [TBL] [Abstract][Full Text] [Related]
15. [Letter: Malignant form of arterial hypertension in elderly patients]. Berkman M; Thillaud P; De Lacoste De Laval A Nouv Presse Med; 1975 Jan; 04(2):114. PubMed ID: 1138225 [No Abstract] [Full Text] [Related]
16. [Importance of renin-angiotensin-aldosterone system in diverse forms of hypertension]. Werning C; Weidmann P; Vetter W; Stiel D; Schweikert HU; Siegenthaler W Schweiz Rundsch Med Prax; 1970 May; 59(20):730-7. PubMed ID: 4321141 [No Abstract] [Full Text] [Related]
17. [The reversing of fundus oculi changes in treated malignant hypertension]. Bock KD; Anlauf M; Schley G; Hengstebeck W; Zimmermann A; Vogel M Verh Dtsch Ges Kreislaufforsch; 1977; 43():229-30. PubMed ID: 613583 [No Abstract] [Full Text] [Related]
18. [Therapeutic approach in malignant hypertension in developing countries]. Frances Y Med Trop (Mars); 1996; 56(3 Suppl):14-6. PubMed ID: 9026610 [No Abstract] [Full Text] [Related]